Cargando…

Overview of growth differentiation factor 15 in metabolic syndrome

Growth and differentiation factor 15 (GDF15) is a member of the transforming growth factor‐β (TGF‐β) superfamily. GDF15 has been linked with several metabolic syndrome pathologies such as obesity and cardiovascular diseases. GDF15 is considered to be a metabolic regulator, although its precise mecha...

Descripción completa

Detalles Bibliográficos
Autores principales:	Asrih, Mohamed, Wei, Shibo, Nguyen, Thanh T., Yi, Hyon‐Seung, Ryu, Dongryeol, Gariani, Karim
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	Reviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10148061/ https://www.ncbi.nlm.nih.gov/pubmed/36992609 http://dx.doi.org/10.1111/jcmm.17725

Ejemplares similares

Sarcopenic obesity: epidemiology, pathophysiology, cardiovascular disease, mortality, and management
por: Wei, Shibo, et al.
Publicado: (2023)

Sex-specific modulation of circulating growth differentiation factor-15 in patients with type 2 diabetes and/or obesity
por: Asrih, Mohamed, et al.
Publicado: (2022)

Sarcopenia and Muscle Aging: A Brief Overview
por: Dao, Tam, et al.
Publicado: (2020)

Growth differentiation factor 15 protects against the aging‐mediated systemic inflammatory response in humans and mice
por: Moon, Ji Sun, et al.
Publicado: (2020)

Growth differentiation factor 15 is a myomitokine governing systemic energy homeostasis
por: Chung, Hyo Kyun, et al.
Publicado: (2017)

Mitochondria-associated programmed cell death as a therapeutic target for age-related disease
por: Nguyen, Thanh T., et al.
Publicado: (2023)

Oral administration of ginseng berry concentrate improves lactate metabolism and increases endurance performance in mice
por: Jin, Eun-Ju, et al.
Publicado: (2023)

Effect of Atorvastatin on Growth Differentiation Factor-15 in Patients with Type 2 Diabetes Mellitus and Dyslipidemia
por: Kim, Ji Min, et al.
Publicado: (2016)

Machine learning-featured Secretogranin V is a circulating diagnostic biomarker for pancreatic adenocarcinomas associated with adipopenia
por: Jo, Yunju, et al.
Publicado: (2022)

Role of Mitogen-Activated Protein Kinase Pathways in Multifactorial Adverse Cardiac Remodeling Associated with Metabolic Syndrome
por: Asrih, Mohamed, et al.
Publicado: (2013)

The Role of Growth Differentiation Factor 15 in Energy Metabolism
por: Chang, Joon Young, et al.
Publicado: (2020)

The impact of cancer cachexia on gut microbiota composition and short-chain fatty acid metabolism in a murine model
por: Jeong, Seung Min, et al.
Publicado: (2023)

Growth differentiation factor-15/adiponectin ratio as a potential biomarker for metabolic syndrome in Han Chinese
por: Zheng, Shuai, et al.
Publicado: (2023)

Growth differentiation factor-15 as a modulator of bone and muscle metabolism
por: Hong, Seok Woo, et al.
Publicado: (2022)

Ketogenic Diet Impairs FGF21 Signaling and Promotes Differential Inflammatory Responses in the Liver and White Adipose Tissue
por: Asrih, Mohamed, et al.
Publicado: (2015)

Clouds over IMD? Perspectives for inherited metabolic diseases in adults from a retrospective cohort study in two Swiss adult metabolic clinics
por: Gariani, Karim, et al.
Publicado: (2020)

Parsonage-Turner Syndrome rather than Zoster Neuritis?
por: Gariani, Karim, et al.
Publicado: (2011)

Serum growth differentiation factor 15 is closely associated with metabolic abnormalities in Chinese pregnant women
por: Li, Enhao, et al.
Publicado: (2021)

Oncogenes, mitochondrial metabolism, and quality control in differentiated thyroid cancer
por: Yi, Hyon-Seung, et al.
Publicado: (2017)

Growth differentiation factor 15 ameliorates nonalcoholic steatohepatitis and related metabolic disorders in mice
por: Kim, Kook Hwan, et al.
Publicado: (2018)

An Overview: The Diversified Role of Mitochondria in Cancer Metabolism
por: Liu, Yu'e, et al.
Publicado: (2023)

Human Botfly: A Case Report and Overview of Differential Diagnosis
por: Shenouda, Mina, et al.
Publicado: (2018)

Growth Differentiation Factor-15 in Immunity and Aging
por: Pence, Brandt D.
Publicado: (2022)

Growth Differentiation Factor 15 Is Associated with Platelet Reactivity in Patients with Acute Coronary Syndrome
por: Mutschlechner, David, et al.
Publicado: (2023)

Correlation between growth differentiation factor-15 and collagen metabolism indicators in patients with myocardial infarction and heart failure
por: Wang, Fang-Fang, et al.
Publicado: (2016)

Differential roles of GDF15 and FGF21 in systemic metabolic adaptation to the mitochondrial integrated stress response
por: Kang, Seul Gi, et al.
Publicado: (2021)

Growth differentiation factor–15 predicts the prognoses of patients with acute coronary syndrome: a meta-analysis
por: Zhang, Shangshi, et al.
Publicado: (2016)

New Insight in Hyperinsulinism/Hyperammonemia Syndrome by Magnetic Resonance Imaging and Spectroscopy
por: Gariani, Karim, et al.
Publicado: (2022)

Pharmacological Overview of the BGP-15 Chemical Agent as a New Drug Candidate for the Treatment of Symptoms of Metabolic Syndrome
por: Pető, Ágota, et al.
Publicado: (2020)

Growth differentiation factor 15 is increased in stable MS
por: Amstad, Andrea, et al.
Publicado: (2020)

Association of Growth and Differentiation Factor 15 in Rheumatoid Arthritis
por: He, Yan-Wei, et al.
Publicado: (2022)

Pathophysiology of NASH in endocrine diseases
por: Gariani, Karim, et al.
Publicado: (2021)

NAFLD: From Mechanisms to Therapeutic Approaches
por: Gariani, Karim, et al.
Publicado: (2022)

Overcoming osteoporosis and beyond: Locomotive syndrome or dysmobility syndrome
por: Yi, Hyon-Seung, et al.
Publicado: (2018)

Growth differentiation factor-15 and prognosis in acute respiratory distress syndrome: a retrospective cohort study
por: Clark, Brendan J, et al.
Publicado: (2013)

Growth Differentiation Factor-15 (GDF-15) Levels Are Associated with Cardiac and Renal Injury in Patients Undergoing Coronary Artery Bypass Grafting with Cardiopulmonary Bypass
por: Kahli, Abdelkader, et al.
Publicado: (2014)

The role of growth differentiation factor 15 in the pathogenesis of primary myelofibrosis
por: Uchiyama, Tatsuki, et al.
Publicado: (2015)

Significance of growth differentiation factor 15 in chronic HCV patients
por: Halim, Mohab H., et al.
Publicado: (2017)

GROWTH DIFFERENTIATION FACTOR 15 IS CORRELATED TO MARKERS OF IMMUNOSENESCENCE IN MONOCYTES
por: Pence, Brandt, et al.
Publicado: (2019)

Growth Differentiation Factor 15 Is Associated With Alzheimer’s Disease Risk
por: Wu, Peng-Fei, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_e5sqaf470b8jpqr1tm17b8v5dv